Effect of scalp nerve block under ultrasound guidance on hemodynamics and postoperative agitation in patients with hypertensive cerebral hemorrhage after craniotomy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500106043

Enrollment

Unknown

Registered

2025-07-16

Start date

2024-07-21

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive intracerebral hemorrhage

Interventions

Control group(A):No intervention, routine general anesthesia.

Ropivacaine SNB Group(B):The anesthetic medication regimen in this group was the same as in the conventional group. Subsequently, ultrasound-guided scalp nerve block was performed. Ropivacaine with a

Dexmedetomidine-Ropivacaine SNB Group(C):The anesthetic medication regimen in this group was the same as in the conventional group. Subsequently, ultrasound-guided scalp nerve block was performed. Rop

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age: 18-60 years old, ASAII- Level IV. In accordance with the relevant diagnostic criteria in the Chinese Guidelines for the Multidisciplinary Diagnosis and Treatment of Hypertensive Cerebral Hemorrhage, the patient was confirmed by head CT or MRI examination. First onset, consistent with surgical indications; The patient was admitted to hospital within 24 hours after the onset of the disease, with blood loss of 30-60 mL; Patients or family members fully understand the risks of surgical grade anesthesia and sign informed consent.

Exclusion criteria

Exclusion criteria: Catheter entry, second surgery. Cerebral hemorrhage caused by traumatic or intracranial space-occupying diseases; Complicated with severe intracranial infection or malignant tumor; Complicated with severe bleeding tendency or brain stem failure; Combined with coagulation dysfunction; Complicated with serious heart, lung and other organ dysfunction; Death or withdrawal from the study for personal reasons during the study period.

Design outcomes

Primary

Measure	Time frame
Hemodynamic parameters;Postoperative agitation;	—

Secondary

Measure	Time frame
Intraoperative dosage of propofol and remifentanil;Time and frequency of postoperative relief analgesia;Postoperative drainage tube related information;	—

Countries

China

Contacts

Public ContactBing Li

Longyan First Affiliated Hospital of Fujian Medical University

75857736@qq.com+86 138 5060 3418

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026